Registered entities
Engrail Therapeutics, Inc.
Reg. No. 84-2517846United States
Innovation
9 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 130 times.
| Year | Filings |
|---|---|
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 6 |
Social engagement
Social engagement: 4.7K social following, 3 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include F-Prime Capital, Forbion, Nan Fung Life Sciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 91% |
| Other / undisclosed | 1 | 9% |